Export streamlining covers significant, nonsignificant risk devices with IDEs -- FDA proposal.
This article was originally published in The Gray Sheet
Executive Summary
EXPORT OF INVESTIGATIONAL DEVICES WITHOUT FDA REVIEW will be allowed for both significant risk devices that have an approved investigational device exemption and nonsignificant risk products that do not require IDEs, the agency says in a proposed rule expected to be published in the Federal Register the week of Nov. 6. The proposal would allow devices that have approved IDEs to be exported to countries that say they will accept the products without FDA review.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.